Tenet Healthcare
About: Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 50 as of July 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Employees: 106,500
0
Funds holding %
of 6,809 funds
0
Analysts bullish %
of 10 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
131% more first-time investments, than exits
New positions opened: 127 | Existing positions closed: 55
15% more capital invested
Capital invested by funds: $12.6B [Q2] → $14.5B (+$1.9B) [Q3]
14% more call options, than puts
Call options by funds: $488M | Put options by funds: $429M
14% more funds holding
Funds holding: 523 [Q2] → 595 (+72) [Q3]
5% more repeat investments, than reductions
Existing positions increased: 208 | Existing positions reduced: 198
7.49% less ownership
Funds ownership: 96.84% [Q2] → 89.35% (-7.49%) [Q3]
17% less funds holding in top 10
Funds holding in top 10: 23 [Q2] → 19 (-4) [Q3]
Research analyst outlook
10 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$140
8%
upside
Avg. target
$182
40%
upside
High target
$217
68%
upside
10 analyst ratings
8 positive
80%
2 neutral
20%
0 negative
0%
JP Morgan Benjamin Rossi 0% 1-year accuracy 0 / 1 met price target | 35%upside $175 | Overweight Assumed | 17 Dec 2024 |
Goldman Sachs Jamie Perse 44% 1-year accuracy 4 / 9 met price target | 8%upside $140 | Neutral Downgraded | 16 Dec 2024 |
Wells Fargo Stephen Baxter 20% 1-year accuracy 8 / 40 met price target | 16%upside $150 | Equal-Weight Downgraded | 25 Nov 2024 |
Raymond James John Ransom 62% 1-year accuracy 8 / 13 met price target | 51%upside $195 | Outperform Downgraded | 22 Nov 2024 |
Barclays Andrew Mok 29% 1-year accuracy 18 / 62 met price target | 47%upside $190 | Overweight Maintained | 8 Nov 2024 |
Financial journalist opinion
Based on 17 articles about THC published over the past 30 days
Positive
Zacks Investment Research
22 hours ago
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Positive
Seeking Alpha
4 days ago
Tenet Healthcare: Walk-In Surgical Care Facilities Are A Key Revenue Driver
Tenet Healthcare is well-positioned for long-term growth due to rising healthcare demand and strategic focus on cost-efficient outpatient services. Financials show strong revenue and net income growth, driven by asset sales, higher operating income, and expense management. Ambulatory Surgery Centers are set for continued revenue growth and are likely to be a key driver of Tenet's continues success.
Positive
Zacks Investment Research
4 days ago
Buy These 4 Stocks With Attractive Interest Coverage Ratio
STRL, LDOS, THC & AMZN's impressive interest coverage ratios highlight that these companies can withstand financial hardships.
Positive
Zacks Investment Research
1 week ago
Is Tenet Healthcare (THC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Negative
Zacks Investment Research
1 week ago
After Plunging -16.78% in 4 Weeks, Here's Why the Trend Might Reverse for Tenet (THC)
The heavy selling pressure might have exhausted for Tenet (THC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Positive
Zacks Investment Research
1 week ago
Wall Street Analysts Look Bullish on Tenet (THC): Should You Buy?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Positive
Zacks Investment Research
2 weeks ago
Tenet (THC) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Tenet (THC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Positive
Zacks Investment Research
2 weeks ago
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Positive
Zacks Investment Research
2 weeks ago
Here is What to Know Beyond Why Tenet Healthcare Corporation (THC) is a Trending Stock
Recently, Zacks.com users have been paying close attention to Tenet (THC). This makes it worthwhile to examine what the stock has in store.
Positive
Zacks Investment Research
2 weeks ago
Why Now is the Time to Buy Tenet Stock After a 15% Drop
THC's cheaper valuation, combined with strong earnings growth and robust free cash flow, makes it an appealing pick for value investors.
Charts implemented using Lightweight Charts™